-
6 days ago | 
drugtopics.com | Killian Meara
Positive topline results have been announced from a phase 2b trial evaluating the efficacy and safety of temtokibart for the treatment of moderate to severe atopic dermatitis in adult patients, LEO Pharma announced in a release.1 The company said it is currently collecting and evaluating the full data set from the study and plans to present it at a later date.
-
6 days ago | 
drugtopics.com | Killian Meara
Roflumilast foam (Zoryve) 0.3% improved signs and symptoms of psoriasis on the scalp and body in patients 12 years of age and older, according to data published in the journal JAMA Dermatology.1 The therapy is currently under FDA review and has a Prescription Drug User Fee Act (PDUFA) action date of May 22, 2025.
-
6 days ago | 
drugtopics.com | Killian Meara |B. Douglas Hoey
Rite Aid, which was once one of the largest pharmacy chains in the United States, recently announced it has filed its second Chapter 11 bankruptcy and will be closing all of its stores or selling them.1 The company, which has continued to face financial hardships since filing for its first Chapter 11 bankruptcy in 2023, said its stores will remain open for the next few months so that patients can continue to receive care.
-
1 week ago | 
drugtopics.com | Killian Meara
Positive results have been announced from a phase 2 trial evaluating a once-daily combination of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) in adult patients, Atea Pharmaceuticals announced in a release.1 The data was presented at the European Association for the Study of the Liver (EASL) Congress 2025, held May 7 to 10 in Amsterdam, Netherlands.
-
1 week ago | 
drugtopics.com | Killian Meara |Natalie DiPietro Mager |Jasmine Cutler
Introducing Scripted for Her, a new podcast offering from Drug Topics®. Hosted by Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University, the podcast aims to help pharmacists provide comprehensive and continuity of care for patients. Each episode will discuss a key topic in the women’s and maternal health spaces, giving pharmacists actionable advice that can improve patient outcomes.
-
1 week ago | 
drugtopics.com | Killian Meara |Kennedy Ferruggia
AI and automation are transforming pharmacy care by improving efficiency and simplifying access. Prescription processing times that once took a full day can now be reduced to just 20 minutes, helping to prevent patient loss and treatment delays. By leveraging data-driven insights, pharmacies can guide patients to the most appropriate treatment options more quickly.
-
1 week ago | 
drugtopics.com | Killian Meara |Kennedy Ferruggia
Advancements in retinal disease treatment are easing burdens for patients with conditions like age-related macular degeneration and diabetic retinopathy. New therapies such as high-dose aflibercept and faricimab allow for longer intervals between injections, improving convenience and adherence. Casey Koch, PharmD, MBA, BCACP, clinical pharmacy coordinator at SelectHealth, notes future options may include gene therapies and multi-targeted antibodies with even longer-lasting effects.
-
1 week ago | 
drugtopics.com | Killian Meara |B. Douglas Hoey
Over 300 US pharmacies have closed since December 2024, largely due to pharmacy benefit managers and stalled legislative reform, according to the American Economic Liberties Project.1 Independent pharmacies, critical in many communities, need to adapt to survive. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association (NCPA), said many are turning to niche services like long-term care at home.
-
2 weeks ago | 
drugtopics.com | Killian Meara |Kennedy Ferruggia
Pharmacy innovation is changing patient care through AI and automation. Sarah Thomas, vice president of sales and commercialization at HealthDyne, said she was able to reduce prescription processing from a day to 20 minutes in her pharmacy. This helped address patient leakage and treatment barriers. Technological advances can also aid patients in navigating complex healthcare systems.
-
2 weeks ago | 
drugtopics.com | Killian Meara |Mark P. Garofoli
Disney sets the gold standard for customer service, mastering how to charge more while still leaving guests eager to return. While pharmacies face different challenges, such as managing controlled substances, insurance barriers, and low reimbursement, there’s much to learn from Disney’s model, says Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, clinical assistant professor and director of experiential learning at West Virginia University School of Pharmacy.
